
1. High Throughput. 2017 Oct 30;6(4). pii: E15. doi: 10.3390/ht6040015.

Study of the Humoral Immune Response towards HCV Genotype 4 Using a Bead-Based
Multiplex Serological Assay.

Filomena A(1), Göpfert JC(2), Duffy D(3)(4)(5), Pol S(6)(7)(8)(9), Abdel-Hamid
M(10), Esmat G(11), Fontanet A(12)(13), Albert ML(14)(15)(16), Joos TO(17),
Schneiderhan-Marra N(18).

Author information: 
(1)NMI Natural and Medical Sciences Institute at the University of Tuebingen,
72770 Reutlingen, Germany. angela.filomena@gmx.de.
(2)NMI Natural and Medical Sciences Institute at the University of Tuebingen,
72770 Reutlingen, Germany. jens.goepfert@nmi.de.
(3)Immunobiology of Dendritic Cells, Institute Pasteur, 75015 Paris, France.
darragh.duffy@pasteur.fr.
(4)Inserm U1223, Institute Pasteur, 75015 Paris, France.
darragh.duffy@pasteur.fr.
(5)Centre for Translational Research, Institute Pasteur, 75015 Paris, France.
darragh.duffy@pasteur.fr.
(6)Immunobiology of Dendritic Cells, Institute Pasteur, 75015 Paris, France.
stanislas.pol@pasteur.fr.
(7)Inserm U1223, Institute Pasteur, 75015 Paris, France.
stanislas.pol@pasteur.fr.
(8)Centre for Translational Research, Institute Pasteur, 75015 Paris, France.
stanislas.pol@pasteur.fr.
(9)Unité d'hépatologie, Groupe Hospitalier Cochin Hôtel-Dieu, Université René
Descartes, 75006 Paris, France. stanislas.pol@pasteur.fr.
(10)Department of Microbiology, Faculty of Medicine, Minia University, Minia
11432, Egypt. vhrl@link.net.
(11)Endemic Medicine and Hepatogastroenterology, Faculty of Medicine, Cairo
University, Cairo 12613, Egypt. gesmat@gamalesmat.com.
(12)Emerging Disease Epidemiology Unit, Institute Pasteur, 75015 Paris, France.
arnaud.fontanet@pasteur.fr.
(13)Conservatoire National des Arts et Métiers, Unité PACRI, 75003 Paris, France.
arnaud.fontanet@pasteur.fr.
(14)Immunobiology of Dendritic Cells, Institute Pasteur, 75015 Paris, France.
matthew.albert@pasteur.fr.
(15)Inserm U1223, Institute Pasteur, 75015 Paris, France.
matthew.albert@pasteur.fr.
(16)Centre for Translational Research, Institute Pasteur, 75015 Paris, France.
matthew.albert@pasteur.fr.
(17)NMI Natural and Medical Sciences Institute at the University of Tuebingen,
72770 Reutlingen, Germany. thomas.joos@nmi.de.
(18)NMI Natural and Medical Sciences Institute at the University of Tuebingen,
72770 Reutlingen, Germany. nicole.schneiderhan@nmi.de.

Hepatitis C is one of the leading causes of hepatocellular carcinoma and remains 
at a high prevalence in Egypt and other resource-limited countries. Several
hepatitis C virus (HCV) genotypes are distributed throughout the world, with
genotype 4 being most common in North and Central Africa. We developed a
multiplex serological assay for the detection of the HCV specific humoral immune 
response, with a focus on genotype 4. For the multiplex HCV assay we used twelve 
antigenic regions of different HCV proteins (core, and non-structural (NS)
proteins NS3, NS4, NS5A, NS5B) and validated the assay technically and
clinically. In comparison to a commercially available test, our assay revealed a 
higher sensitivity for genotype 4, and is therefore more suited for studying
immune seroconversion in samples from acutely infected Egyptian HCV patients.
Furthermore, our assay discriminates acutely and chronically infected HCV
patients. Of 296 well characterized HCV patient samples, 83.9% of the acute
samples and 86.5% of the chronic samples could be correctly classified. In sum,
this newly developed serological HCV assay has a higher sensitivity for HCV
genotype 4, and can thus improve diagnostic accuracy. Through the discrimination 
of acutely and chronically infected HCV patients the assay may be useful in
supporting clinical management of HCV patients.

DOI: 10.3390/ht6040015 
PMCID: PMC5748594
PMID: 29855459 

Conflict of interest statement: A.F., J.C.G., D.D., M.A.H., G.E., M.L.A., A.F.,
T.O.J., N.S.M. have no conflict of interest. S.P. was Speaker for Bristol-Myers
Squibb (BMS), Boehringer Ingelheim, Janssen, Gilead, Merck Sharp & Dohme (MSD),
Abbvie; received Grants from BMS, Gilead, MSD and is Board member of BMS,
Boehringer Ingelheim, Janssen, Gilead, MSD, Abbvie.

